WILMINGTON, MA — Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, announced this week that its QS-B220 desktop explosives and drugs trace detector has been deployed to over 160 airports across the United States and Europe over the past twelve months. Over 1,000 units were sold to support ECAC demand to European airports in 14 countries, and substantial follow-on orders continue to be in play in the region.
Implant Sciences won the 1,170 unit order from the US Transportation Security Administration (TSA) in November, 2014. These units, which began shipping in December 2015, are continuing to be deployed across nearly 200 United States airports. Implant Sciences also announced the capture of the 122 unit order from the Canadian Air Transport Security Authority (CATSA) in January, 2016. Those units are also currently being deployed to airports across Canada.
“The success Implant Sciences has achieved in the aviation security market is significant. Our company, long known for its cutting-edge technical solutions, is recognized and chosen by the leading procurers in aviation security operations around the world. In winning competitive bid after competitive bid, Implant Sciences’ QS-B220 is now the most widely deployed non-rad ETD in the world,” stated Dr. Darryl Jones, Implant Sciences’ Executive Vice President.
“We have made great progress in aviation security and we have a number of other markets with noteworthy opportunities in view. We are proud of our tremendous accomplishments in the aviation security sector and look forward to continuing to execute on delivering mission critical and life saving technology to security operations and professionals,” added Robert Liscouski, Implant Sciences’ President.
About the QS-B220 Desktop Explosives Trace Detector
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company’s team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 70 countries worldwide. The Company’s ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., ECAC in Europe, CAAC and the Ministry of Public Safety in China, Russia FSB, STAC in France, and the German Ministry of the Interior. It has also received the 2015 GSN Airport/Seaport/Border Security Award for “Best Security Checkpoint”. For further details on the Company and its products, please visit the Company’s website at http://www.implantsciences.com.
(NOTE: The above press release is from Implant Sciences.)
Like Wilmington Apple on Facebook. Follow Wilmington Apple on Twitter. Subscribe to Wilmington Apple’s daily email newsletter HERE. Got a comment, question, photo, press release, or news tip? Email wilmingtonapple@gmail.com.
Wilmington Apple 